These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17446761)

  • 1. Erythromycin as a prokinetic: is the overall benefit corroborated?
    Singh NK
    Crit Care Med; 2007 May; 35(5):1446; author reply 1446-7. PubMed ID: 17446761
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks.
    Hawkyard CV; Koerner RJ
    J Antimicrob Chemother; 2007 Mar; 59(3):347-58. PubMed ID: 17289772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How should we use prokinetic drugs in patients who are intolerant to enteral feeding?
    Asai T
    Crit Care Med; 2007 Feb; 35(2):650-1. PubMed ID: 17251716
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of prokinetics in the preterm infant.
    Lam HS; Ng PC
    Curr Opin Pediatr; 2011 Apr; 23(2):156-60. PubMed ID: 21178622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prokinetic agents in critical care.
    Doherty WL; Winter B
    Crit Care; 2003 Jun; 7(3):206-8. PubMed ID: 12793865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythromycin and gastroparesis? Off-licence use: uncertain efficacy for a poorly defined disorder.
    Prescrire Int; 1999 Feb; 8(39):13-5. PubMed ID: 10557568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on: The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks.
    Deane A; Young R
    J Antimicrob Chemother; 2008 Jan; 61(1):227; author reply 227-8. PubMed ID: 17981832
    [No Abstract]   [Full Text] [Related]  

  • 8. Prokinetic therapy for feed intolerance in critical illness: one drug or two?
    Nguyen NQ; Chapman M; Fraser RJ; Bryant LK; Burgstad C; Holloway RH
    Crit Care Med; 2007 Nov; 35(11):2561-7. PubMed ID: 17828038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromycin for prokinesis: imprudent prescribing?
    Dall'Antonia M; Wilks M; Coen PG; Bragman S; Millar MR
    Crit Care; 2006 Feb; 10(1):112. PubMed ID: 16420656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Any news from the prokinetic front?
    Deane AM; Chapman MJ; Abdelhamid YA
    Curr Opin Crit Care; 2019 Aug; 25(4):349-355. PubMed ID: 31247631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin as a prokinetic agent in newborns--useful or doubtful. Commentary on Y. Mansi et al.: Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants (Neonatology 2011;100:290-294).
    Ng PC
    Neonatology; 2011; 100(3):297-8. PubMed ID: 21701224
    [No Abstract]   [Full Text] [Related]  

  • 12. Prokinetic drugs for feed intolerance in critical illness: current and potential therapies.
    Deane AM; Fraser RJ; Chapman MJ
    Crit Care Resusc; 2009 Jun; 11(2):132-43. PubMed ID: 19485878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of oral erythromycin for the treatment of gastrointestinal dysmotility in preterm infants.
    Ng PC
    Neonatology; 2009; 95(2):97-104. PubMed ID: 19218823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric prokinetic motility therapy to facilitate early enteral nutrition in the intensive care unit.
    Miskovitz P
    Crit Care Med; 2002 Jun; 30(6):1386-7. PubMed ID: 12072701
    [No Abstract]   [Full Text] [Related]  

  • 15. Promotility agents in the intensive care unit.
    Zaloga GP; Marik P
    Crit Care Med; 2000 Jul; 28(7):2657-9. PubMed ID: 10921616
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimal method of postpyloric tube placement still unclear.
    Hallstrom CK; Jacobs BR
    Crit Care Med; 2003 Jan; 31(1):315-6. PubMed ID: 12545040
    [No Abstract]   [Full Text] [Related]  

  • 17. [Erythromycin in therapy of cyclic vomiting syndrome].
    Pavlović M; Radlović N; Leković Z; Berenji K
    Srp Arh Celok Lek; 2007; 135(5-6):339-41. PubMed ID: 17633325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why use erythromycin to manage gastroparesis?
    King JE
    Nursing; 2007 Jun; 37(6):20. PubMed ID: 17538420
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mechanism and clinical application of erythromycin as a gastrointestinal prokinetic agent in children].
    Yang Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):102-4. PubMed ID: 18289489
    [No Abstract]   [Full Text] [Related]  

  • 20. Gastroparesis after retroperitoneal surgery successfully treated with erythromycin.
    Heidenreich A; Wille S; Hofmann R
    J Urol; 2000 Feb; 163(2):545. PubMed ID: 10647677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.